Americas vs Ghana: Proportion of the target population who received a 3rd dose of
Americas
79.0%
in 2024
Ghana
96.0%
in 2024
Americas rank
14th
Ghana rank
16th
Proportion of the target population who received a 3rd dose of over time
- Americas
- Ghana
How they compare
Ghana currently reports 96.0% against 79.0% in Americas, a difference of 17.0%.
That makes Ghana's figure about 1.2 times Americas's.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was Americas ahead.
Americas ranks 14th and Ghana ranks 16th of 37 groups.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 81.5% | 88.0% | 6.5% | Ghana |
| 2020s | 76.4% | 96.8% | 20.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Americas or Ghana?
- Ghana, at 96.0% against 79.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Americas and Ghana?
- 17.0%, with Ghana ahead.
- How many years of comparable data are there for Americas and Ghana?
- 13 years are reported by both, from 2012 to 2024.
- How do Americas and Ghana rank globally for proportion of the target population who received a 3rd dose of?
- Americas ranks 14th and Ghana ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.